CORRECTING and REPLACING Luminex Corporation to Present At JPMorgan Healthcare Conference

  
    
  
  
    
      In the second graph, first sentence of the release dated Jan. 4, 2008 
      the time of the presentation is incorrect. The correct time should be 
      3:00 p.m. Pacific time (6:00 p.m. Eastern time) on Tuesday, January 8, 
      2008 (sted: 12:00 p.m. Pacific time (3:00 p.m. Eastern time) on Tuesday, 
      January 8, 2008).
    
    
      The corrected release reads:
    
    
      LUMINEX CORPORATION TO PRESENT AT JPMORGAN HEALTHCARE CONFERENCE
    
    
      Luminex Corporation (NASDAQ:LMNX) today announced that management will 
      present at the 26th Annual JPMorgan Healthcare Conference to be held 
      January 7-10, 2008, in San Francisco.
    
    
      The investor presentation by Patrick J. Balthrop, president and chief 
      executive officer, and Harriss T. Currie, chief financial officer, will 
      begin at 3:00 p.m. Pacific time (6:00 p.m. Eastern time) on Tuesday, 
      January 8, 2008. The presentation will be webcast live and may be 
      accessed at Luminex Corporation's website at http://www.luminexcorp.com. 
      Simply log on to the web at the address above, go to the Company section 
      and access the Investor Relations link. Please go to the website at 
      least 15 minutes prior to the event to register, download and install 
      any necessary audio/video software. If you are unable to participate 
      during the live webcast, the presentation will be archived for one year 
      on the website using the 'replay' link.
    
    
      Luminex Corporation develops, manufactures and markets proprietary 
      biological testing technologies with applications throughout the life 
      sciences industry. The Company's xMAP® system 
      is an open-architecture, multi-analyte technology platform that delivers 
      fast, accurate and cost-effective bioassay results to markets as diverse 
      as pharmaceutical drug discovery, clinical diagnostics and biomedical 
      research, including the genomics and proteomics research markets. The 
      Company's xMAP technology is sold worldwide and is already in use in 
      leading research laboratories as well as major pharmaceutical, 
      diagnostic and biotechnology companies. Further information on Luminex 
      Corporation or xMAP can be obtained on the Internet at www.luminexcorp.com.